Interferon alpha-2c therapy of patients with chronic myelogenous leukemia : long-term results of a multicenter phase-II study
- Author
- THALER, J1 ; GASTL, G; UTERMANN, G; KÜHR, T; AULITZKY, W; HUBER, C; FLUCKINGER, T; NIEDERWIESER, D; HUBER, H; SEEWANN, H; SILL, H; LANG, A; FALK, M; DUBA, C
[1] Department of Internal Medicine, University Hospital, Anichstrasse 35, 6020 Innsbruck, Austria
Austrian Biological Response Modifier (BRM) Study Group, Austria - Source
Annals of hematology (Print). 1996, Vol 72, Num 6, pp 349-356, 7 p ; ref : 31 ref
- ISSN
- 0939-5555
- Scientific domain
- Hematology
- Publisher
- Springer, Berlin
- Publication country
- Germany
- Document type
- Article
- Language
- English
- Keyword (fr)
- Chromosome Ph1 Chronique Cytogénétique Essai clinique phase II Etude multicentrique Homme Immunothérapie Interféron alpha Leucémie myéloïde Pronostic Traitement Interféron alpha 2c Aberration chromosomique Chromosome anormal Cytokine Hémopathie maligne Myéloprolifératif syndrome
- Keyword (en)
- Philadelphia chromosome Chronic Cytogenetics Phase II trial Multicenter study Human Immunotherapy Alpha interferon Chronic myelocytic leukemia Prognosis Treatment Chromosomal aberration Abnormal chromosome Cytokine Malignant hemopathy Myeloproliferative syndrome
- Keyword (es)
- Cromosoma Ph1 Crónico Citogenética Ensayo clínico fase II Estudio multicéntrico Hombre Inmunoterapia Interferón alfa Leucemia mieloidea Pronóstico Tratamiento Aberración cromosómica Cromosoma anormal Citoquina Hemopatía maligna Mieloproliferativo síndrome
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments / 002B02R Antineoplastic agents / 002B02R03 Immunotherapy
- Discipline
- Pharmacological treatments
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 3119565
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1007/s002770050185 
https://dx.doi.org/10.1007/s002770050185
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:21:\"10.1007\/s002770050185\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:125:\"Interferon alpha-2c therapy of patients with chronic myelogenous leukemia : long-term results of a multicenter phase-II study\";s:9:\"\u0000*\u0000jtitle\";s:28:\"Annals of hematology (Print)\";s:9:\"\u0000*\u0000stitle\";s:21:\"Ann. hematol. (Print)\";s:7:\"\u0000*\u0000date\";s:4:\"1996\";s:9:\"\u0000*\u0000volume\";s:2:\"72\";s:8:\"\u0000*\u0000issue\";s:1:\"6\";s:8:\"\u0000*\u0000spage\";s:3:\"349\";s:8:\"\u0000*\u0000epage\";s:3:\"356\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0939-5555\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"THALER\";s:10:\"\u0000*\u0000aufirst\";s:1:\"J\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:13:{i:0;s:8:\"GASTL, G\";i:1;s:11:\"UTERMANN, G\";i:2;s:8:\"K\u00dcHR, T\";i:3;s:11:\"AULITZKY, W\";i:4;s:8:\"HUBER, C\";i:5;s:13:\"FLUCKINGER, T\";i:6;s:15:\"NIEDERWIESER, D\";i:7;s:8:\"HUBER, H\";i:8;s:10:\"SEEWANN, H\";i:9;s:7:\"SILL, H\";i:10;s:7:\"LANG, A\";i:11;s:7:\"FALK, M\";i:12;s:7:\"DUBA, C\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:125:\"Interferon alpha-2c therapy of patients with chronic myelogenous leukemia : long-term results of a multicenter phase-II study\";s:8:\"\u0000*\u0000place\";s:6:\"Berlin\";s:6:\"\u0000*\u0000pub\";s:8:\"Springer\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"7\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:21:\"10.1007\/s002770050185\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:125:\"Interferon alpha-2c therapy of patients with chronic myelogenous leukemia : long-term results of a multicenter phase-II study\";s:9:\"\u0000*\u0000jtitle\";s:28:\"Annals of hematology (Print)\";s:9:\"\u0000*\u0000stitle\";s:21:\"Ann. hematol. (Print)\";s:7:\"\u0000*\u0000date\";s:4:\"1996\";s:9:\"\u0000*\u0000volume\";s:2:\"72\";s:8:\"\u0000*\u0000issue\";s:1:\"6\";s:8:\"\u0000*\u0000spage\";s:3:\"349\";s:8:\"\u0000*\u0000epage\";s:3:\"356\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0939-5555\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"THALER\";s:10:\"\u0000*\u0000aufirst\";s:1:\"J\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:13:{i:0;s:8:\"GASTL, G\";i:1;s:11:\"UTERMANN, G\";i:2;s:8:\"K\u00dcHR, T\";i:3;s:11:\"AULITZKY, W\";i:4;s:8:\"HUBER, C\";i:5;s:13:\"FLUCKINGER, T\";i:6;s:15:\"NIEDERWIESER, D\";i:7;s:8:\"HUBER, H\";i:8;s:10:\"SEEWANN, H\";i:9;s:7:\"SILL, H\";i:10;s:7:\"LANG, A\";i:11;s:7:\"FALK, M\";i:12;s:7:\"DUBA, C\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:125:\"Interferon alpha-2c therapy of patients with chronic myelogenous leukemia : long-term results of a multicenter phase-II study\";s:8:\"\u0000*\u0000place\";s:6:\"Berlin\";s:6:\"\u0000*\u0000pub\";s:8:\"Springer\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"7\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:21:\"10.1007\/s002770050185\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:21:\"10.1007\/s002770050185\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:125:\"Interferon alpha-2c therapy of patients with chronic myelogenous leukemia : long-term results of a multicenter phase-II study\";s:9:\"\u0000*\u0000jtitle\";s:28:\"Annals of hematology (Print)\";s:9:\"\u0000*\u0000stitle\";s:21:\"Ann. hematol. (Print)\";s:7:\"\u0000*\u0000date\";s:4:\"1996\";s:9:\"\u0000*\u0000volume\";s:2:\"72\";s:8:\"\u0000*\u0000issue\";s:1:\"6\";s:8:\"\u0000*\u0000spage\";s:3:\"349\";s:8:\"\u0000*\u0000epage\";s:3:\"356\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0939-5555\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"THALER\";s:10:\"\u0000*\u0000aufirst\";s:1:\"J\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:13:{i:0;s:8:\"GASTL, G\";i:1;s:11:\"UTERMANN, G\";i:2;s:8:\"K\u00dcHR, T\";i:3;s:11:\"AULITZKY, W\";i:4;s:8:\"HUBER, C\";i:5;s:13:\"FLUCKINGER, T\";i:6;s:15:\"NIEDERWIESER, D\";i:7;s:8:\"HUBER, H\";i:8;s:10:\"SEEWANN, H\";i:9;s:7:\"SILL, H\";i:10;s:7:\"LANG, A\";i:11;s:7:\"FALK, M\";i:12;s:7:\"DUBA, C\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:125:\"Interferon alpha-2c therapy of patients with chronic myelogenous leukemia : long-term results of a multicenter phase-II study\";s:8:\"\u0000*\u0000place\";s:6:\"Berlin\";s:6:\"\u0000*\u0000pub\";s:8:\"Springer\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"7\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:21:\"10.1007\/s002770050185\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:125:\"Interferon alpha-2c therapy of patients with chronic myelogenous leukemia : long-term results of a multicenter phase-II study\";s:9:\"\u0000*\u0000jtitle\";s:28:\"Annals of hematology (Print)\";s:9:\"\u0000*\u0000stitle\";s:21:\"Ann. hematol. (Print)\";s:7:\"\u0000*\u0000date\";s:4:\"1996\";s:9:\"\u0000*\u0000volume\";s:2:\"72\";s:8:\"\u0000*\u0000issue\";s:1:\"6\";s:8:\"\u0000*\u0000spage\";s:3:\"349\";s:8:\"\u0000*\u0000epage\";s:3:\"356\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0939-5555\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"THALER\";s:10:\"\u0000*\u0000aufirst\";s:1:\"J\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:13:{i:0;s:8:\"GASTL, G\";i:1;s:11:\"UTERMANN, G\";i:2;s:8:\"K\u00dcHR, T\";i:3;s:11:\"AULITZKY, W\";i:4;s:8:\"HUBER, C\";i:5;s:13:\"FLUCKINGER, T\";i:6;s:15:\"NIEDERWIESER, D\";i:7;s:8:\"HUBER, H\";i:8;s:10:\"SEEWANN, H\";i:9;s:7:\"SILL, H\";i:10;s:7:\"LANG, A\";i:11;s:7:\"FALK, M\";i:12;s:7:\"DUBA, C\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:125:\"Interferon alpha-2c therapy of patients with chronic myelogenous leukemia : long-term results of a multicenter phase-II study\";s:8:\"\u0000*\u0000place\";s:6:\"Berlin\";s:6:\"\u0000*\u0000pub\";s:8:\"Springer\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"7\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:21:\"10.1007\/s002770050185\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:125:\"Interferon alpha-2c therapy of patients with chronic myelogenous leukemia : long-term results of a multicenter phase-II study\";s:9:\"\u0000*\u0000jtitle\";s:28:\"Annals of hematology (Print)\";s:9:\"\u0000*\u0000stitle\";s:21:\"Ann. hematol. (Print)\";s:7:\"\u0000*\u0000date\";s:4:\"1996\";s:9:\"\u0000*\u0000volume\";s:2:\"72\";s:8:\"\u0000*\u0000issue\";s:1:\"6\";s:8:\"\u0000*\u0000spage\";s:3:\"349\";s:8:\"\u0000*\u0000epage\";s:3:\"356\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0939-5555\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"THALER\";s:10:\"\u0000*\u0000aufirst\";s:1:\"J\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:13:{i:0;s:8:\"GASTL, G\";i:1;s:11:\"UTERMANN, G\";i:2;s:8:\"K\u00dcHR, T\";i:3;s:11:\"AULITZKY, W\";i:4;s:8:\"HUBER, C\";i:5;s:13:\"FLUCKINGER, T\";i:6;s:15:\"NIEDERWIESER, D\";i:7;s:8:\"HUBER, H\";i:8;s:10:\"SEEWANN, H\";i:9;s:7:\"SILL, H\";i:10;s:7:\"LANG, A\";i:11;s:7:\"FALK, M\";i:12;s:7:\"DUBA, C\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:125:\"Interferon alpha-2c therapy of patients with chronic myelogenous leukemia : long-term results of a multicenter phase-II study\";s:8:\"\u0000*\u0000place\";s:6:\"Berlin\";s:6:\"\u0000*\u0000pub\";s:8:\"Springer\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"7\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
